Cargando…
The Notch Ligand Jagged1 as a Target for Anti-Tumor Therapy
The Notch pathway is increasingly attracting attention as a source of therapeutic targets for cancer. Ligand-induced Notch signaling has been implicated in various aspects of cancer biology; as a consequence, pan-Notch inhibitors and therapeutic antibodies targeting one or more of the Notch receptor...
Autores principales: | Li, Demin, Masiero, Massimo, Banham, Alison H., Harris, Adrian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174884/ https://www.ncbi.nlm.nih.gov/pubmed/25309874 http://dx.doi.org/10.3389/fonc.2014.00254 |
Ejemplares similares
-
Molecular Basis for Jagged-1/Serrate Ligand Recognition by the Notch Receptor
por: Whiteman, Pat, et al.
Publicado: (2013) -
Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors
por: Silva, Gabriela, et al.
Publicado: (2023) -
Notch signaling: its roles and therapeutic potential in hematological malignancies
por: Gu, Yisu, et al.
Publicado: (2016) -
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
por: Fiaschetti, Giulio, et al.
Publicado: (2014) -
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?
por: Negri, Francesca, et al.
Publicado: (2023)